---
document_datetime: 2023-09-21 17:48:23
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/topotecan-eagle-epar-all-authorised-presentations_en.pdf
document_name: topotecan-eagle-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3596333
conversion_datetime: 2025-12-28 15:18:18.365247
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## EU Number

EU/1/11/744/001

EU/1/11/744/002

Name

Topotecan

Eagle

Topotecan

Eagle

Strength

Pharmaceutical

Form

3 mg/ml       Concentrate for solution for

infusion

Concentrate for solution for

infusion

15 mg/5

ml

Route of

Administration

Intravenous use

Intravenous use

Packaging vial (glass)

vial (glass)

<!-- image -->

5 ml

Medicinal Product no longer authorised

## Package size

1 vial

1 vial